# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 3bvl:A (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
2 | 3bvl:A (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
3 | 3bvl:B (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
4 | 3bvl:B (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
5 | 3bvl:C (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
6 | 3bvl:C (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
7 | 3bvl:D (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
8 | 3bvl:D (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
9 | 3bvl:E (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
10 | 3bvl:E (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
11 | 3bvl:F (1.8) | BS01 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A | |
12 | 3bvl:F (1.8) | BS02 | FE | 1.16.3.2 | GO:0004322 ... | Q9ZLI1 | N/A |